LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

LLY

1,022.7

+0.26%↑

JNJ

246.77

+0.74%↑

ABBV

224.2

-1.89%↓

NVS

163.46

-1.15%↓

MRK

121.78

+0.14%↑

Kodu・Aktsiate loetelu・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Suletud

SektorTervishoid

34.23 -2.53

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

34.04

Max

35.49

Põhinäitajad
By Trading Economics
Sissetulek	11M 51M
Müük	39M 239M
P/E Sektori keskmine	11.36 110.024
Aktsiakasum	1.08
Kasumimarginaal	21.242
Töötajad	268
EBITDA	14M 73M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+36.76% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	24. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	387M 2.1B
Eelmine avamishind	36.76
Eelmine sulgemishind	34.23

Uudiste sentiment

By Acuity

53%

47%

289 / 351 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Weak Bullish Evidence

29.8 / N/A Toetus ja vastupanu

Harmony Biosciences Holdings Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

19. veebr 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

19. veebr 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19. veebr 2026, 23:39 UTC

Omandamised, ülevõtmised, äriostud

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19. veebr 2026, 23:38 UTC

Tulu

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19. veebr 2026, 23:37 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19. veebr 2026, 23:34 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19. veebr 2026, 23:34 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19. veebr 2026, 23:33 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19. veebr 2026, 23:33 UTC

Tulu

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19. veebr 2026, 22:13 UTC

Market Talk

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19. veebr 2026, 22:08 UTC

Tulu

Fairfax Financial 4Q Rev $8.11B >FFH.T

19. veebr 2026, 22:07 UTC

Tulu

Eldorado Gold 4Q EPS $1.19 >ELD.T

19. veebr 2026, 22:06 UTC

Tulu

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19. veebr 2026, 22:05 UTC

Tulu

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19. veebr 2026, 22:05 UTC

Tulu

Eldorado Gold 4Q Rev $577.2M >ELD.T

19. veebr 2026, 22:04 UTC

Tulu

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19. veebr 2026, 22:04 UTC

Tulu

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19. veebr 2026, 21:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

19. veebr 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. veebr 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19. veebr 2026, 21:43 UTC

Tulu

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19. veebr 2026, 21:42 UTC

Omandamised, ülevõtmised, äriostud

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19. veebr 2026, 21:42 UTC

Tulu

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19. veebr 2026, 21:41 UTC

Tulu

Correct: St Barbara 1H Net Loss A$249,000

19. veebr 2026, 21:40 UTC

Tulu

St Barbara 1H Net Loss A$249 Million

19. veebr 2026, 21:39 UTC

Tulu

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19. veebr 2026, 21:37 UTC

Tulu

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19. veebr 2026, 21:37 UTC

Tulu

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Võrdlus sarnastega

Hinnamuutus

Harmony Biosciences Holdings Inc Prognoos

Hinnasiht

By TipRanks

36.76% tõus

12 kuu keskmine prognoos

Keskmine 48.25 USD 36.76%

Kõrge 55 USD

Madal 42 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Harmony Biosciences Holdings Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

5 ratings

Osta

Hoia

Müü

Põhineb 5 analüütiku instrumendi Harmony Biosciences Holdings Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

29.8 / N/AToetus ja vastupanu

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Sentiment

By Acuity

289 / 351 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.